Picture of Sequana Medical NV logo

SEQUA — Sequana Medical NV News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Sequana Medical: Positive Pre-Clinical And Clinical Proof-Of-Concept Data On Its DSR Therapy

Jan 10 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * SEQUANA MEDICAL ANNOUNCES FIRST-IN-HUMAN DATA OF DIRECT
SODIUM
REMOVAL (DSR) THERAPY PUBLISHED IN CIRCULATION
    * DATA DEMONSTRATES POTENTIAL FOR TREATMENT OF VOLUME
OVERLOAD DUE
TO HEART FAILURE
    * POSITIVE PRE-CLINICAL AND CLINICAL PROOF-OF-CONCEPT DATA
OF
SEQUANA MEDICAL'S INNOVATIVE DSR THERAPY

Source text for Eikon:  ID:nGNE51RHXq 
Further company coverage:  SEQUA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Sequana Medical NV

See all news